Research and Development

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …

The first green shoots of  recovery in the global economy – assuming of course they are not going to be …

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …

Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …

Contract research organisation Parexel has launched a new web-based technology platform for late phase clinical research that it says makes …